GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CELLUMED Co Ltd (XKRX:049180) » Definitions » Loans Receivable

CELLUMED Co (XKRX:049180) Loans Receivable : ₩0 Mil (As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CELLUMED Co Loans Receivable?

CELLUMED Co's Loans Receivable for the quarter that ended in Sep. 2024 was ₩0 Mil.


CELLUMED Co Loans Receivable Historical Data

The historical data trend for CELLUMED Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CELLUMED Co Loans Receivable Chart

CELLUMED Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CELLUMED Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

CELLUMED Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


CELLUMED Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of CELLUMED Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


CELLUMED Co Business Description

Traded in Other Exchanges
N/A
Address
Acetechno Tower 9 402, Gasan-dong, Geumcheon-gu, Seoul, KOR, 153-782
CELLUMED Co Ltd is a Korean company which is engaged in manufacturing and sale of medical equipment and biosimilars. Its products portfolio includes allografts for tissue repair, bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration and biosimilars such as bone morphogenetic protein 2 (BMP2) reagents and others. It also produces medical devices, such as spinal fixation systems, joint replacements, and navigation systems.

CELLUMED Co Headlines

No Headlines